Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo.
J Neuroinflammation
; 16(1): 28, 2019 Feb 08.
Article
in En
| MEDLINE
| ID: mdl-30736794
ABSTRACT
BACKGROUND:
Inappropriate contact between the immune system and the central nervous system is thought to be a cause of demyelination. We previously reported the ability of the class IV semaphorin, Semaphorin4A (Sema4A), to induce apoptosis in human oligodendrocytes; however, these results have yet to be translated to an in vivo setting. Importantly, HIV-associated neurocognitive disorder remains a significant complication for patients on combined anti-retroviral therapy, with white matter damage seen on MRI.METHODS:
Human cerebrospinal fluid and serum was assayed for Sema4A using a Sema4A-specific ELISA. Wild-type mice were injected with Sema4A via stereotaxic infusion. Data was assessed for significance using unpaired t tests, comparing the corpus callosum of PBS-injected mice versus Sema4A-injected mice.RESULTS:
Here, we demonstrate elevated levels of Sema4A in the cerebrospinal fluid and serum of people with HIV infection. Furthermore, we demonstrate that direct injection of Sema4A into the corpus callosum of mice results in loss of myelin architecture and decreased myelin, concomitant with apoptosis of mature myelinating oligodendrocytes. Sema4A injection also causes increased activation of microglia.CONCLUSIONS:
Taken together, our data further establish Sema4A as a potentially significant mediator of demyelinating diseases and a direct connection between the immune system and oligodendrocytes.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligodendroglia
/
Demyelinating Diseases
/
Semaphorins
Type of study:
Etiology_studies
Limits:
Adult
/
Animals
/
Humans
Language:
En
Journal:
J Neuroinflammation
Journal subject:
NEUROLOGIA
Year:
2019
Document type:
Article
Affiliation country: